Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN126,92127,08-1,53
Msft0,05
Nokia9,2569,2922,90
IBM-1,69
Mercedes-Benz Group AG49,52549,55-0,50
PFE-0,78
28.04.2026 1:38:57
Indexy online
AD Index online
select
AD Index online
 

  • 27.04.2026
Cardinal Health (CAH, NY Consolidated)
Závěr k 27.4.2026 Změna (%) Změna (USD) Objem obchodů (USD)
202,34 1,25 2,49 212 242 578
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.
Financial Summary: BRIEF: For the six months ended 31 December 2025, Cardinal Health Inc revenues increased 21% to $129.64B. Net income increased 12% to $917M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Pharmaceutical and Speciality solution segment income decrease of 35% to $687M, Other segment income decrease of 19% to $179M.



  • Poslední aktualizace:
Management společnosti
Data nejsou k dispozici